NO942110L - Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav - Google Patents

Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav

Info

Publication number
NO942110L
NO942110L NO942110A NO942110A NO942110L NO 942110 L NO942110 L NO 942110L NO 942110 A NO942110 A NO 942110A NO 942110 A NO942110 A NO 942110A NO 942110 L NO942110 L NO 942110L
Authority
NO
Norway
Prior art keywords
actinoplanes
lipopeptides
preparation
pharmacological effect
effect method
Prior art date
Application number
NO942110A
Other languages
English (en)
Norwegian (no)
Other versions
NO942110D0 (no
Inventor
Peter Hammann
Johannes Meiwes
Gerhard Seibert
Laszlo Vertesy
Joachim Wink
Astrid Markus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO942110D0 publication Critical patent/NO942110D0/no
Publication of NO942110L publication Critical patent/NO942110L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO942110A 1993-06-08 1994-06-07 Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav NO942110L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319007 1993-06-08

Publications (2)

Publication Number Publication Date
NO942110D0 NO942110D0 (no) 1994-06-07
NO942110L true NO942110L (no) 1994-12-09

Family

ID=6489896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942110A NO942110L (no) 1993-06-08 1994-06-07 Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav

Country Status (27)

Country Link
US (1) US6194383B1 (fr)
EP (2) EP0864584B1 (fr)
JP (1) JP2660161B2 (fr)
KR (2) KR0174264B1 (fr)
AT (2) ATE174604T1 (fr)
AU (1) AU672691B2 (fr)
CA (1) CA2125376C (fr)
CY (1) CY2190B1 (fr)
CZ (1) CZ285322B6 (fr)
DE (2) DE59409616D1 (fr)
DK (2) DK0864584T3 (fr)
ES (2) ES2153224T3 (fr)
FI (1) FI942660L (fr)
GR (2) GR3029591T3 (fr)
HU (1) HU217177B (fr)
IL (2) IL109917A (fr)
MA (1) MA23216A1 (fr)
NO (1) NO942110L (fr)
NZ (1) NZ260682A (fr)
OA (1) OA10066A (fr)
PL (2) PL180230B1 (fr)
PT (1) PT864584E (fr)
RU (1) RU2117672C1 (fr)
SK (1) SK281830B6 (fr)
TW (1) TW455591B (fr)
UY (1) UY23762A1 (fr)
ZA (1) ZA943983B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
KR100291406B1 (ko) * 1999-05-13 2001-05-15 이길정 직거 염색기용 기어박스
KR100423751B1 (ko) * 1999-05-18 2004-03-22 심선희 지그염색기의 직물이송속도 유지장치
KR100331966B1 (ko) * 1999-10-23 2002-04-10 윤기룡 염색된 직물의 직물권취장치
US6696412B1 (en) * 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6511962B1 (en) 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
US7125844B2 (en) 2002-01-03 2006-10-24 Migenix Inc. Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
US20040157803A1 (en) * 2002-03-04 2004-08-12 Williams Deryck J. Nematicidal fatty acid and fatty acid ester related compounds
US6887900B2 (en) * 2002-03-04 2005-05-03 Divergence, Inc. Nematicidal compositions and methods
JP2007536200A (ja) * 2003-07-17 2007-12-13 ミジェニックス インコーポレイテッド リポペプチド抗生物質誘導体の組成物およびその使用方法
US7368629B2 (en) * 2004-02-04 2008-05-06 Divergence, Inc. Nucleic acids encoding anthelmintic agents and plants made therefrom
DE102004060750A1 (de) 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
CA2781666C (fr) 2009-11-23 2017-02-21 Cubist Pharmaceuticals, Inc. Compositions de lipopeptides et procedes apparentes
KR101151878B1 (ko) 2010-06-08 2012-05-31 미원상사주식회사 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물
WO2013012101A1 (fr) * 2011-07-15 2013-01-24 미원상사주식회사 Sel de tripeptides d'acide gras et composition antibactérienne en contenant
FR2980802B1 (fr) * 2011-10-03 2014-12-26 Univ Lille 1 Sciences Et Technologies Ustl Procede de production de biosurfactants et dispositif de mise en œuvre

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000397A (en) 1975-03-21 1976-12-28 Spectra-Physics, Inc. Signal processor method and apparatus
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
AU6462094A (en) 1994-12-15
CA2125376A1 (fr) 1994-12-09
NO942110D0 (no) 1994-06-07
FI942660A7 (fi) 1994-12-09
JPH0797394A (ja) 1995-04-11
KR950000890A (ko) 1995-01-03
PL303716A1 (en) 1994-12-12
HUT69937A (en) 1995-09-28
CZ285322B6 (cs) 1999-07-14
ES2153224T3 (es) 2001-02-16
IL109917A (en) 2001-03-19
ZA943983B (en) 1995-01-27
HU9401465D0 (en) 1994-08-29
NZ260682A (en) 1995-11-27
DE59409616D1 (de) 2001-01-25
HU217177B (hu) 1999-12-28
MA23216A1 (fr) 1994-12-31
JP2660161B2 (ja) 1997-10-08
ATE174604T1 (de) 1999-01-15
EP0864584B1 (fr) 2000-12-20
UY23762A1 (es) 1994-05-03
TW455591B (en) 2001-09-21
CY2190B1 (en) 2002-11-08
PL180230B1 (pl) 2001-01-31
RU2117672C1 (ru) 1998-08-20
US6194383B1 (en) 2001-02-27
EP0629636B1 (fr) 1998-12-16
CZ138194A3 (en) 1994-12-15
ES2127312T3 (es) 1999-04-16
EP0629636A1 (fr) 1994-12-21
IL125450A0 (en) 1999-03-12
DK0629636T3 (da) 1999-08-23
PL179581B1 (pl) 2000-09-29
KR100319563B1 (ko) 2002-02-19
IL109917A0 (en) 1994-10-07
GR3035204T3 (en) 2001-04-30
SK68594A3 (en) 1995-01-12
EP0864584A1 (fr) 1998-09-16
FI942660L (fi) 1994-12-09
ATE198209T1 (de) 2001-01-15
FI942660A0 (fi) 1994-06-06
CA2125376C (fr) 2000-08-08
SK281830B6 (sk) 2001-08-06
RU94022485A (ru) 1996-04-20
DK0864584T3 (da) 2001-02-05
OA10066A (fr) 1996-10-14
PT864584E (pt) 2001-05-31
AU672691B2 (en) 1996-10-10
HK1012009A1 (en) 1999-07-23
DE59407475D1 (de) 1999-01-28
GR3029591T3 (en) 1999-06-30
KR0174264B1 (ko) 1999-02-01

Similar Documents

Publication Publication Date Title
RU94022485A (ru) Липопептиды из actinoplanes sp, способ их получения и применение
Knott-Hunziker et al. Active sites of β-lactamases. The chromosomal β-lactamases of Pseudomonas aeruginosa and Escherichia coli
TW334432B (en) Tricyclic amide and urea compounds
MX9708967A (es) Metodo para la purificacion de plasmidos a gran escala.
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
IL111257A0 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
AU4257389A (en) Method for cultivation of bacteria
AU3824095A (en) Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
AU5450998A (en) Methods for controlling above-ground plant diseases using antibiotic-producing strains of (bacillus sp.)
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
IL110723A0 (en) System using tubular photobioreactors for the industrial culture of photosynthetic microorganisms
DK0686195T3 (da) Fremgangsmåde og system til forhöjet produktion af kommercielt vigtige exoproteiner i grampositive bakterier
PL316085A1 (en) Novel method of isolating clavulanic acids and pharmaceutically acceptable salts thereof from fermentation broth of streptomyces sp. p 6621 ferm p 2804
NO982207L (no) Fremmedproteinsekresjonsvektorer, transformerte mikroorganismer og fremgangsmÕte for fremstilling av hirudiner
IN190120B (fr)
DE60126802D1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese
EP0379395A3 (fr) Antibiotique L53-18A et sa préparation
AU2534595A (en) Angiotensin ii for improving fertilization
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
AU656525B2 (en) Method of preparation of vaccines, and the use of the vaccines thus prepared
GB9321302D0 (en) Enzyme
DE68913128D1 (de) Verfahren zur Herstellung von L-Alanin-Dehydrogenase und Mikroorganismusstamm des Genus Sporolactobacillus.
AU2977389A (en) Method for renovating ring chamber furnaces
NO20004613L (no) FremgangsmÕte for fremstilling av et tetrapeptid
GB9321301D0 (en) Enzyme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application